🇺🇸 DMPA in United States

FDA authorised DMPA on 23 September 1960

Marketing authorisations

FDA — authorised 23 September 1960

  • Application: NDA012541
  • Marketing authorisation holder: PFIZER
  • Local brand name: DEPO-PROVERA
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA

  • Status: approved

DMPA in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is DMPA approved in United States?

Yes. FDA authorised it on 23 September 1960; FDA has authorised it.

Who is the marketing authorisation holder for DMPA in United States?

PFIZER holds the US marketing authorisation.